SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001769456-22-000003
Filing Date
2022-02-14
Accepted
2022-02-11 17:33:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 LEXARIA - 13G LEXX13G.htm SC 13G 27462
  Complete submission text file 0001769456-22-000003.txt   29121
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G | Act: 34 | File No.: 005-85256 | Film No.: 22623034
SIC: 2834 Pharmaceutical Preparations

Mailing Address 211 CONGRESS STREET 7TH FLOOR BOSTON MA 02110
Business Address 211 CONGRESS STREET 7TH FLOOR BOSTON MA 02110 617-912-4972
Invenomic Capital Management LP (Filed by) CIK: 0001769456 (see all company filings)

IRS No.: 810795975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G